User menu

Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population

Bibliographic reference Cruyssen, Bert Vander ; Durez, Patrick ; Westhovens, Rene ; De Clerck, Luc ; Peretz, Ann ; et. al. Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population.Annual Meeting of the British-Society-Rheumatology/Spring Meeting of British Health Professional in Rheumatology (Liverpool (England), Apr 22-25, 2007). In: Rheumatology, Vol. 47, p. II39-II39 (2008)
Permanent URL http://hdl.handle.net/2078.1/59284